Biogen, Inc. (BIIB)

191.97 -0.11 (-0.06%) USD  |  NASDAQ  |  Feb 20, 16:00
191.60 -0.37 (-0.19%) After-Hours: 17:35
More

Biogen EPS Diluted from Extraordinaries (Quarterly)

EPS Diluted from Extraordinaries (Quarterly) Chart

View EPS Diluted from Extraordinaries (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Extraordinaries (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Extraordinaries (Quarterly) Benchmarks

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Merck & Co., Inc. --
AbbVie, Inc. --
Stoke Therapeutics, Inc. --
Alnylam Pharmaceuticals, Inc. --